Summary We studied 100 patients with non-Hodgkin's lymphoma, 44 patients with Hodgkin's disease and 100 controls for the prevalence of the EcoRI restriction fragment polymorphism of the L-myc oncogene. No difference in the frequency of the three genotypes (LL, LS, SS) was found between the patient and control groups. However, the S allele was found to occur more frequently in the non-Hodgkin's lymphoma patients (X2 = 4.57, P = 0.032). These data confirm an earlier report and suggest that the presence of the S allele is associated with susceptibility to non-Hodgkin's lymphoma.
Associations between restriction fragment length polymorphisms (RFLPs) of known oncogenes and a predisposition to develop cancer have been reported by a number of authors (Krontiris et al., 1985; Lidereau et al., 1985; Heighway et al., 1986) . One of the most extensively studied oncogene RFLPs is an EcoRI RFLP of the L-myc oncogene. Digestion of DNA with EcoRI results in two alleles of 10 kb (L) and 6.6 kb (S). The S allele is reported to occur more frequently in male patients with bone and soft-tissue sarcomas (Kato et al., 1990) , in oral cancer patients with poor to moderately differentiated tumours (Saranath et al., 1990 ) and in patients with leukaemia and lymphoma (Chenevix-Trench et al., 1989) . Furthermore, an increased susceptibility to metastasis in lung (Kawashima et al., 1988) , renal (Kakehi & Yoshida, 1989) and gastric cancer ) is associated with the presence of the S allele. However, a negative association between an increased susceptibility to metastases in Norwegian lung cancer patients and the S allele has been reported (Tefre et al., 1990) . In this study we have investigated the frequency of the S allele in non-Hodgkin's lymphoma (NHL) patients and Hodgkin's disease (HD) patients compared with controls. DNA isolation and Southern blot analysis DNA was isolated from peripheral blood samples by the method of Ciulla et al. (1988) . Briefly, 5 ml of peripheral blood was lysed with 45 ml of cold lysis buffer (0.32 M sucrose, 10 mM Tris-HCl pH 7.5, 5 mM magnesium chloride and 1% Triton X-100) and then centrifuged for 10 min at 1,000 g. The pellet was resuspended in 5 ml of 4.0 M guanidine isothiocyanate, 25 mm sodium acetate and 0.84% P-mercaptoethanol and rocked gently for 20 min. The DNA was precipitated by the addition of an equal volume of isopropanol and resuspended in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). A 3 ytg aliquot of DNA was digested with EcoRI, electrophoresed in a 0.8% agarose gel, transferred to Hybond N+ nylon membrane by alkaline transfer (Chomczynski & Qasba, 1984) and hybridised with a 32p_ labelled probe prepared by the random priming method of Feinberg and Vogelstein (1983) . A 1.8 kb SmaI-EcoRI Lmyc fragment, pJB327 (Nau et al., 1985) , excised from low gelling temperature agarose, was used as the probe. Washes were carried out at a final stringency of 0.3 x SSC and the autoradiographs exposed for 1-3 days on Kodak XAR-5 film at -80°C.
Materials and methods

Patients and controls
Statistics
The frequency of the three genotypes and the two alleles in the patient and control groups were compared using the X2 test.
Results
EcoRI-digested DNA probed with the L-myc probe results in two fragments of 10 kb (L) and 6.6 kb (S) which are due to an EcoRI restriction site polymorphism (Nau et al., 1985) . The distribution of the three genotypes (LL, LS, SS) in the control and the patient groups is shown in Table I . Although there is an increased number of patients with an SS genotype in the NHL group, x2 analysis showed that there was no difference in the distribution of the three genotypes between either of the two patient groups and the controls, and all are in accord with Hardy-Weinberg equilibrium. However, there was a significant difference in the allele frequency between the controls and the NHL patients. The S allele occurred more frequently in the NHL patients than the normal control (X2 = 4.57, 1 d.f., P= 0.032).
Discussion
Our finding of an increased frequency of the S allele in the NHL patients confirms the results of Chenevix-Trench et al. (1989) , who reported that the S allele was more common in a P.E. CROSSEN et al. (1989) used two sets of normals, geriatric (mean age 77 years) and laboratory workers (age unknown, but presumably younger). The increased frequency of the S allele in the combined NHL and ALL patients was only found when they were compared with the unselected (laboratory workers) controls. In addition, they found a significant difference in the genotype frequency between the geriatric population and the unselected controls and suggested that the LL homozygotes are less likely to reach old age. Neither our patient nor control group falls into the geriatric category described by Chenevix-Trench et al. (1989) so we do not know if there is a reduced incidence of LL homozygotes in the New Zealand elderly population.
The frequency of the L allele in our control population as well as the unselected controls of Chenevix-Trench et al. (1989) is considerably higher than in the other reported studies of normals (Table II) . The reason for this variation is unclear but may reflect differences in the ethnic composition of the various control groups. Table II shows that Norwegians, Japanese, Indians, American Whites, English Caucasians and geriatric Australians of European descent have similar allele frequencies, whereas American Blacks have an increased frequency of the S allele. In contrast, our normal controls, as well as the unselected controls of Chenevix-Trench et al. (1989) , both of whom are of European descent, have an increased frequency of the L allele. Differing allele frequencies related to ethnicity are unlikely to be a factor in the increased frequency of the S allele in the NHL patients in our study because both our control and patient groups were Caucasians of European descent. Nevertheless, Table II does show the importance of ensuring that the ethnic composition of the control and patient groups is similar.
How the presence of a polymorphic EcoRI site is related not only to a susceptibility to NHL but also to an increased tendency to metastasis in other forms of cancer is not clear. The nucleotide sequence of the S allele has been determined (Kawashima et al., 1992) and, as expected, differs by 1 bp in the EcoRI site. In addition, there was a deletion of 8 bp in intron 2 and it was suggested that these differences may influence the transcription or splicing of the S allele. An alternative explanation is that the L-myc gene is not involved, but is in linkage disequilibrium with a gene or genes that are important in NHL as well as other forms of cancer. Further studies of well-characterised large patient groups of defined ethnicity are needed to ascertain the role of the S allele in carcinogenesis.
